xAnts

xAnts

en-SG

Privia Health (NASDAQ:PRVA) Surprises With Q4 Sales But Full-Year Sales Guidance Misses Expectations

2025-02-27MSN
Privia Health (NASDAQ:PRVA) Surprises With Q4 Sales But Full-Year Sales Guidance Misses Expectations

Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced in Q4 CY2024, with sales up 4.6% year on year to $460.9 million. On the other hand, the company's full-year revenue guidance of $1.85 billion at the midpoint came in 2. ...Read more

Recommendations